Publications
View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
May 2023
Inmunogenicidad y seguridad de la vacuna recombinante con adyuvante contra el zoster en Pacientes con Artritis Reumatoide recibiendo agentes anticelulares biológicos o inhibidores de JAK: Un estudio observacional prospectivo
Int JMol Sci 2023;24(8):6967 doi 10.3390/ijms24086967
A prospective observational study showed that recombinant zoster vaccine (RZV) immunogenicity is not impaired in RA patients on JAK inhibitors or anti-cellular bDMARDs.